Most cited papers from Agennix (United States)

Agennix (United States)

What are the most cited papers from Agennix (United States)?

The most cited paper from Agennix (United States) is "Lactoferrin Acts as an Alarmin to Promote the Recruitment and Activation of APCs and Antigen-Specific Immune Responses" (Gonzalo de la Rosa, De Yang, Poonam Tewary et al., 2008), with 196 citations. Next come "A System for Production of Commercial Quantities of Human Lactoferrin: A Broad Spectrum Natural Antibiotic" (191) and "Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells" (140).

Published TypeFieldAccessAuthorsCitations

Showing 41 of 41 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Lactoferrin Acts as an Alarmin to Promote the Recruitment and Activation of APCs and Antigen-Specific Immune Responses Gonzalo de la Rosa, De Yang, Poonam Tewary et al. · The Journal of Immunology Open access	May 2008	196
2	A System for Production of Commercial Quantities of Human Lactoferrin: A Broad Spectrum Natural Antibiotic Pauline P. Ward, Christopher S. Piddington, Gráinne A. Cunningham et al. · Nature Biotechnology	May 1995	191
3	Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells Michela Spadaro, Cristiana Caorsi, Patrizia Ceruti et al. · The FASEB Journal	25 Mar 2008	140
4	Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy Atul Varadhachary, Jeffrey S. Wolf, Karel Petrak et al. · International Journal of Cancer Open access	23 Apr 2004	136
5	Lactoferrin protects neonatal rats from gut-related systemic infection Lynn Edde, Ronaldo B. Hipolito, Freda F. Y. Hwang et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology	Nov 2001	135
6	Neutrophil and endothelial adhesive function during human fetal ontogeny Claudia Nußbaum, Anna Gloning, Monika Pruenster et al. · Journal of Leukocyte Biology Open access	12 Dec 2012	101
7	Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: Murine Ortholog of the Fletcher Trait J. Eileen Bird, Patricia L. Smith, Xinkang Wang et al. · Thrombosis and Haemostasis	2012	83
8	In situ growth of superconducting YBaCuO using reactive electron-beam coevaporation Nancy A. Missert, Robert B. Hammond, Johan E. Mooij et al. · IEEE Transactions on Magnetics	Mar 1989	80
9	Regulation of epidermal Langerhans cell migration by lactoferrin Marie Cumberbatch, Rebecca Jane Dearman, Sonia Uribe-Luna et al. · Immunology Open access	May 2000	80
10	A Phase 2 Randomized, Double-Blind, Placebo–Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis* Kalpalatha K. Guntupalli, Nathan C. Dean, Peter E. Morris et al. · Critical Care Medicine	20 Feb 2013	74
11	Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans Christopher E.M. Griffiths, Marie Cumberbatch, Simon C Tucker et al. · British Journal of Dermatology	Apr 2001	74
12	A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral Talactoferrin in Combination with Carboplatin and Paclitaxel in Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer Raghunadharao Digumarti, Yenyun Wang, Ganapathi S. Raman et al. · Journal of Thoracic Oncology Open access	29 Apr 2011	69
13	Novel therapies for Helicobacter pylori infection Opekun, EL‐ZAIMAITY, Osato et al. · Alimentary Pharmacology & Therapeutics	1999	61
14	Talactoferrin Stimulates Wound Healing With Modulation of Inflammation Jose Engelmayer, Paul Blezinger, Atul Varadhachary · Journal of Surgical Research	11 Jan 2008	60
15	Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial) Suresh S. Ramalingam et al. · Annals of Oncology Open access194 authors	20 Sep 2013	57
16	Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study Thomas E. Lyons, Michael S. Miller, Thomas E Serena et al. · The American Journal of Surgery	21 Dec 2006	57
17	Talactoferrin in Severe Sepsis Jean‐Louis Vincent, John C. Marshall, R. Phillip Dellinger et al. · Critical Care Medicine	25 May 2015	53
18	Randomized Controlled Trial of Talactoferrin Oral Solution in Preterm Infants Michael P. Sherman, David H. Adamkin, Victoria Niklas et al. · The Journal of Pediatrics Open access	31 May 2016	51
19	Recombinant Human Lactoferrin is Effective in the Treatment of Helicobacter felis-infected Mice Elizabeth J. Dial, Jim J. Romero, Denis R. Headon et al. · Journal of Pharmacy and Pharmacology Open access	Dec 2000	50
20	Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma Eric W. Jonasch, Walter Michael Stadler, Ronald M. Bukowski et al. · Cancer	16 May 2008	44
21	A platelet target for venous thrombosis? P2Y1 deletion or antagonism protects mice from vena cava thrombosis J. Eileen Bird, Xinkang Wang, Patricia L. Smith et al. · Journal of Thrombosis and Thrombolysis	15 May 2012	34
22	A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock Peter E. Morris, Brian R. Zeno, Andrew C. Bernard et al. · Critical Care Open access	17 Feb 2012	28
23	Lactoferrin-enhanced anoikis: A defense against neonatal necrotizing enterocolitis Michael P. Sherman, Karel Petrak · Medical Hypotheses	2005	23
24	Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors Teresa Gray Hayes, Gerald Steven Falchook, Atul Varadhachary · Investigational New Drugs	23 Feb 2009	23
25	Oral pretreatment with recombinant human lactoferrin limits trauma-hemorrhagic shock–induced gut injury and the biological activity of mesenteric lymph Julie Y. Son, Benjamin Chandler, Eleonora Feketova et al. · Journal of Surgical Research	18 Oct 2013	14
26	Regulation by Lactoferrin of Epidermal Langerhans Cell Migration Ian Kimber, Marie Cumberbatch, Rebecca Jane Dearman et al. · Advances in experimental medicine and biology Book chapter	1998	8
27	Fortis-M, a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Oral Talactoferrin Alfa with Best Supportive Care in Patients with Advanced Non-Small Cell Lung Cancer Following Two or More Prior Regimens- by the Fortis-M Study Group Suresh S. Ramalingam, Jeffrey Crawford, Alex Y. C. Chang et al. · Annals of Oncology Open access	Sep 2012	6
28	C1-05: Oral talactoferrin extends survival in patients with refractory NSCLC in a randomized, placebo-controlled, phase 2 trial Purvish Mahendra Parikh, Yenyun Wang, Arati Ranade et al. · Journal of Thoracic Oncology Open access	Aug 2007	5
29	The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates Leigh Jessica Marcus, Robert L. Murphy, Elizabeth Fox et al. · Cancer Chemotherapy and Pharmacology Open access	25 Jun 2011	4
30	Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patients Jonathan Wesley Riess, Nupur Bhattacharya, Kim Blenman et al. · Immunopharmacology and Immunotoxicology Open access	5 Feb 2014	4
31	9.13 Industrially Relevant Enzymatic Reductions Jeffrey C. Moore, Christopher K. Savile, Sachin Pannuri et al. · Elsevier eBooks Book chapter	2012	4
32	Assessment of Cardiac Safety for PPARγ Agonists in Rodent Models of Heart Failure: A Translational Medicine Perspective Xinkang Wang · Current Molecular Pharmacology	May 2012	3
33	Long-Term Outcomes After Critical Illness Greg S. Martin · Critical Care Medicine	17 Apr 2013	2
34	Research During Pandemics Niranjan “Tex” Kissoon, John C. Marshall · Critical Care Medicine	17 Apr 2013	1
35	Generation and charaterization of a spasmolytic polypeptide (TFF2) knockout mouse Douglas R. Taupin, James J. Farrell, Theodore J. Koh et al. · Gastroenterology Open access	Apr 2000	1
36	Determinants of Long-Term Mortality After Critical Illness Greg S. Martin · Critical Care Medicine	17 Apr 2013	0
37	Recombinant human lactoferrin protects the intestinal mucosa against NSAID-induced injury Elizabeth J. Dial, Jimmy J. Romero, Norma Diaz-Mayoral et al. · Gastroenterology Open access	Apr 2000	0
38	Inhibition by lactoferrin of allergen-induced dendritic cell migration to draining lymph nodes Ian Kimber, Rebecca J. Dearman, Marie Cumberbatch et al. · Immunology Letters	May 1997	0
39	Lactoferrin Modulates Endotoxin-Mediated Activation of Pulmonary Alveolar Macrophages Michael P. Sherman, Serap Sencer, Xiaojun Zhou et al. · Pediatric Research	Apr 1999	0
40	Talactoferrin Alfa, a novel immunomodulatory agent with anti-cancer activity in phase II clinical trials. Atul Varadhachary, Michela Spadaro, Jose Engelmayer et al. · Cancer Research	15 Apr 2006	0
41	Talactoferrin is a novel maturation factor for human dendritic cells Michela Spadaro, Cristiana Caorsi, Patrizia Ceruti et al. · Cancer Research	May 2008	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.